See how your answers relate to your colleagues'.

Which below medication is currently in Phase 3 clinical development for the treatment of NASH?
a. Tirzepatide
b. Resmetirom
c. Glimepiride
d. None of the above

Submit is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation, Madrigal Pharmaceuticals, Medtronic and Stanford University.
©2023 CogniMed Inc. All rights reserved.